1. Home
  2. CDNA vs RAMP Comparison

CDNA vs RAMP Comparison

Compare CDNA & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$53.96

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$37.72

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
RAMP
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
CDNA
RAMP
Price
$53.96
$37.72
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$28.00
$35.60
AVG Volume (30 Days)
1.0M
997.2K
Earning Date
04-28-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22500.00
EPS
2.13
0.28
Revenue
$48,324,000.00
$812,940,000.00
Revenue This Year
$16.01
$11.18
Revenue Next Year
$11.31
$9.09
P/E Ratio
$25.48
$135.32
Revenue Growth
18.93
9.03
52 Week Low
$13.95
$21.71
52 Week High
$55.16
$38.23

Technical Indicators

Market Signals
Indicator
CDNA
RAMP
Relative Strength Index (RSI) 69.87 49.82
Support Level $45.74 $37.65
Resistance Level N/A $37.91
Average True Range (ATR) 2.17 0.14
MACD -0.00 0.00
Stochastic Oscillator 85.84 35.23

Price Performance

Historical Comparison
CDNA
RAMP

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that empowers marketers and media owners to deliver and measure marketing performance everywhere it matters. Its data collaboration network seamlessly unites data across advertisers, ad tech platforms, publishers, data providers, and commerce media networks, unlocking insights that deliver transformational consumer experiences and drive measurable business outcomes. The group's platform is engineered for AI agent accessibility, facilitating autonomous data collaboration between the specialized AI agents utilized by customers and partners and the networked platform. It generates the geographic revenue from the United States, followed by Europe, Asia-Pacific ("APAC"), and Other.

Share on Social Networks: